1 |
Lee JW, Chung HY, Cerrati EW, O TM, Waner M. The natural history of soft tissue hypertrophy, bony hypertrophy, and nodule formation in patients with untreated head and neck capillary malformations. Dermatol Surg 2015;41:1241-5.
DOI
|
2 |
Koster PH, Bossuyt PM, van der Horst CM, Gijsbers GH, van Gemert MJ. Characterization of portwine stain disfigurement. Plast Reconstr Surg 1998;102:1210-6.
DOI
|
3 |
Lee JW, Chung HY. Capillary malformations (portwine stains) of the head and neck: natural history, investigations, laser, and surgical management. Otolaryngol Clin North Am 2018;51: 197-211.
DOI
|
4 |
Young AE. Pathogenesis of vascular malformations. In: Mulliken JB, Young AE, editors. Vascular birthmarks: hemangiomas and malformations. Philadelphia: Saunders; 1988. p. 107-13.
|
5 |
Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 1995;95:951-60.
DOI
|
6 |
Greene AK, Perlyn CA, Alomari AI. Management of lymphatic malformations. Clin Plast Surg 2011;38:75-82.
DOI
|
7 |
Greene AK, Alomari AI. Management of venous malformations. Clin Plast Surg 2011;38:83-93.
DOI
|
8 |
Limaye N, Wouters V, Uebelhoer M, Tuominen M, Wirkkala R, Mulliken JB, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 2009;41:118-24.
DOI
|
9 |
Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181-90.
DOI
|
10 |
Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol 2004;140:971-6.
|
11 |
Young AE, Mulliken JB. Arteriovenous malformations. In: Mulliken JB, Young AE, editors. Vascular birthmarks: hemangiomas and malformations. Philadelphia: Saunders; 1988. p. 228-45.
|
12 |
Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg 2010;125: 1185-94.
DOI
|
13 |
Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240-9.
DOI
|
14 |
Greene AK, Orbach DB. Management of arteriovenous malformations. Clin Plast Surg 2011;38:95-106.
DOI
|
15 |
Greene AK, Kim S, Rogers GF, Fishman SJ, Olsen BR, Mulliken JB. Risk of vascular anomalies with Down syndrome. Pediatrics 2008;121:e135-40.
DOI
|
16 |
Greene AK. Vascular anomalies: current overview of the field. Clin Plast Surg 2011;38:1-5.
DOI
|
17 |
Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-22.
|
18 |
Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-22.
DOI
|
19 |
ISSVA. ISSVA classification for vascular anomalies [Internet]. Amsterdam: International Society for the Study of Vascular Anomalies [cited 2018 Dec 20]. Available from: http://www.issva.org/classification.
|
20 |
Greene AK. Management of hemangiomas and other vascular tumors. Clin Plast Surg 2011;38:45-63.
DOI
|
21 |
Drolet BA, Swanson EA, Frieden IJ; Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 2008;153:712-5.e1.
DOI
|
22 |
Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983; 18:894-900.
DOI
|
23 |
Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-7.
DOI
|
24 |
Bowers RE, Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch Dermatol 1960;82:667-80.
DOI
|
25 |
North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11-22.
DOI
|
26 |
Johnson WC. Pathology of cutaneous vascular tumors. Int J Dermatol 1976;15:239-70.
DOI
|
27 |
Cordoro KM, Speetzen LS, Koerper MA, Frieden IJ. Physiologic changes in vascular birthmarks during early infancy: mechanisms and clinical implications. J Am Acad Dermatol 2009;60:669-75.
DOI
|
28 |
Mills CM, Lanigan SW, Hughes J, Anstey AV. Demographic study of port wine stain patients attending a laser clinic: family history, prevalence of naevus anaemicus and results of prior treatment. Clin Exp Dermatol 1997;22:166-8.
DOI
|
29 |
Renfro L, Geronemus RG. Anatomical differences of portwine stains in response to treatment with the pulsed dye laser. Arch Dermatol 1993;129:182-8.
DOI
|
30 |
Orten SS, Waner M, Flock S, Roberson PK, Kincannon J. Portwine stains: an assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg 1996;122:1174-9.
DOI
|
31 |
Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet 2007;16:R140-9.
DOI
|
32 |
Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000;37:517-84.
DOI
|
33 |
Wright DR, Frieden IJ, Orlow SJ, Shin HT, Chamlin S, Schaffer JV, et al. The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations. Arch Dermatol 2009;145:287-93.
|
34 |
Gonzalez ME, Burk CJ, Barbouth DS, Connelly EA. Macrocephaly-capillary malformation: a report of three cases and review of the literature. Pediatr Dermatol 2009;26:342-6.
DOI
|
35 |
Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013;368:1971-9.
DOI
|